Absci (ABSI) Cash & Equivalents (2020 - 2026)

Absci has reported Cash & Equivalents for 7 years, with the latest figure at $8.6 million in Q1 2026.

• Quarterly Cash & Equivalents fell 81.64% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 81.64% YoY) and the FY2025 annual result came in at $20.0 million, down 51.41% from the prior year.
• Cash & Equivalents retreated to $8.6 million in Q1 2026 per ABSI's latest filing, from $20.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $226.0 million in Q1 2022 and troughed at $8.6 million in Q1 2026.
• A 5-year average of $56.6 million and a median of $47.0 million in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents plunged 94.95% in 2023, then jumped 415.65% in 2024.
• Over 5 years, Cash & Equivalents stood at $60.0 million in 2022, then increased by 20.69% to $72.4 million in 2023, then slumped by 43.05% to $41.2 million in 2024, then slumped by 51.41% to $20.0 million in 2025, then slumped by 56.92% to $8.6 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $8.6 million, $20.0 million, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.